Showing results (51-60 of 100) with videos related to
Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1991
The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesionsN R Soman, P Correa, B A Ruiz, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspotW R Kobertz, D Wang, G N Wogan, et al.Cancer Research|August 1, 1975
Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinineG N Wogan, S Paglialunga, M C Archer, et al.Carcinogenesis|January 1, 1980
Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liverR G Croy, J E Nixon, R O Sinnhuber, et al.Cancer Research|December 11, 1976
Effect of hepatocarcinogens on the binding of glucocorticoid-receptor complex in rat liver nucleiT W Kensler, W F Busby, N E Davidson, et al.Carcinogenesis|October 1, 1984
Tumorigenicity of fluoranthene in a newborn mouse lung adenoma bioassayW F Busby, M E Goldman, P M Newberne, et al.Carcinogenesis|January 1, 1981
Interaction of aflatoxin B2 with rat liver DNA and histones in vivoJ D Groopman, K W Fowler, W F Busby, et al.Carcinogenesis|September 1, 1989
Formation of DNA and hemoglobin adducts of fluoranthene after single and multiple exposuresN J Gorelick, D A Hutchins, S R Tannenbaum, et al.Cancer Research|April 1, 1994
Molecular biomarkers for aflatoxins and their application to human cancer preventionJ D Groopman, G N Wogan, B D Roebuck, et al.Carcinogenesis|June 1, 1993
Quantitative analysis of aflatoxin-albumin adductsF Z Sheabar, J D Groopman, G S Qian, et al.Pageof 10